The world's largest pharmaceutical companies have been calling the institute asking if they can test their lines of a drug now used to treat patients with HIV, another retrovirus, to see if their anti-viral drugs can be adapted to treat Chronic Fatigue Syndrome patients.
"They want us to send them the (XMRV) retrovirus so they can screen huge libraries of compounds and see what they have that could work," Mikovits said. "They already have drugs to treat HIV, so they could redesign a compound for the XMRV virus. Since they already have FDA approval, they could get something out to people fast."
Among the drug companies lining up are LabCorp and Quest, two of the largest diagnostic companies in the world, Mikovits said.
The drug companies will pay for the Reno institute's cell lines, the established cultures that will grow the XMRV retrovirus so they can test their antiviral drugs on them, she said.
"What makes this especially exciting is patients, who basically have been ridiculed and poked fun at for having a disease that has been given very little credibility, finally would have hope," Lombardi said. "And it could lead to real treatment strategies."
......are you listening, White, Sharpe, Chalder, Wessley, Crippen, etc?
Very useful link, many thanks,
ReplyDeleteSevere ME patient.
From the Reno Gazette-Journal:
ReplyDeleteThe world's largest pharmaceutical companies have been calling the institute asking if they can test their lines of a drug now used to treat patients with HIV, another retrovirus, to see if their anti-viral drugs can be adapted to treat Chronic Fatigue Syndrome patients.
"They want us to send them the (XMRV) retrovirus so they can screen huge libraries of compounds and see what they have that could work," Mikovits said. "They already have drugs to treat HIV, so they could redesign a compound for the XMRV virus. Since they already have FDA approval, they could get something out to people fast."
Among the drug companies lining up are LabCorp and Quest, two of the largest diagnostic companies in the world, Mikovits said.
The drug companies will pay for the Reno institute's cell lines, the established cultures that will grow the XMRV retrovirus so they can test their antiviral drugs on them, she said.
http://www.rgj.com/article/20091101/NEWS/911010342/1321/Medical-breakthrough-puts-Reno-in-spotlight
ReplyDelete"What makes this especially exciting is patients, who basically have been ridiculed and poked fun at for having a disease that has been given very little credibility, finally would have hope," Lombardi said. "And it could lead to real treatment strategies."
......are you listening, White, Sharpe, Chalder, Wessley, Crippen, etc?